Business reporter focused on the health-care economy's effects on patient health, costs, and privacy Education: University of Arizona, BS in Journalism Chris Rowland reports on the business of health care for The Washington Post, which he joined in November 2018. He began his career at the Brattleboro Reformer, a small newspaper in southern Vermont, and remained focused on New England in subsequent posts at the Providence Journal and the Boston Globe. He developed expertise in government accountability coverage, the intersection of business and politics, and health care. Rowland became an editor in 2007 and oversaw the Globe's coverage of the Massachusetts State House and Boston City Hall. In 2009, he moved to Washington to lead the Globe D.C. bureau, assigning and editing stories with a national and regional outlook. Honors & Awards:
Everett McKinley Dirksen Award, 2013, awarded to Boston Globe Washington Bureau for 19-part "Broken City" series on congressional gridlock and dysfunction
Society of American Business Editors and Writers,Project Award, 2005, shared for coverage of the Medicare prescription benefit law
Edited Globe work recognized for the Merriman Smith Memorial Award (2016, about the Iran nuclear pact) and as finalist for the Gerald Loeb Award (2011, about business activities of retired generals) and finalist for the Goldsmith Prize for investigative reporting (2010, about Massachusetts lawmakers’ pensions)
The GOP battles over a trillion-dollar stimulus deal. Ahead of the November election, President Trump guts a landmark environmental law. And, how to avoid a devastating potential kink in the vaccine supply chain.
In its race to control covid-19, the federal government is spending billions in agreements with pharmaceutical companies to subsidize development of medicines. But it is employing a looser standard of federal contracting that avoids some rules that protect taxpayer investments, said Knowledge Ecology International.